ED searches Gujarat pharma firm for alleged FEMA violations Ruby Khatun Khatun8 Aug 2017 9:26 AM ISTNew Delhi: The ED on Saturday conducted multiple searches against a Gujarat-based pharma company for alleged "suspicious" transactions in violation of...
Zydus Cadila gets USFDA nod to market anti-dementia drug Ruby Khatun Khatun8 Aug 2017 9:25 AM ISTNew Delhi: Zydus Cadila on Saturday said it has received final nod from the US health regulator to market Memantine Hydrochloride extended-release...
Government commercialised ayurvedic medicines for diabetes, arthritis Ruby Khatun Khatun8 Aug 2017 9:22 AM ISTNew Delhi: Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Lok Sabha has informed that two...
Natco Pharma Q1 profit up 97 percent at Rs 93.7 crore Ruby Khatun Khatun8 Aug 2017 9:20 AM ISTNew Delhi: Drug firm Natco Pharma on Monday reported a 97.26 per cent rise in consolidated profit after tax to Rs 93.7 crore for the first quarter...
FDA Warns against Triamcinolone and Moxifloxacin injections in Eye Ruby Khatun Khatun8 Aug 2017 9:18 AM ISTThe U.S. Food and Drug Administration (FDA) received adverse event reports on April 5 and June 1, 2017, and conducted follow-up, concerning at least...
Senate reauthorizes FDA to collect fees from drugmakers Ruby Khatun Khatun8 Aug 2017 9:15 AM ISTThe U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new...
WHO prequalifies first generic hepatitis C medicine and first HIV self-test Ruby Khatun Khatun7 Aug 2017 10:20 AM ISTWHO prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to...
3.16 percent of drugs in India not of standard quality, admits Ministry Ruby Khatun Khatun7 Aug 2017 10:06 AM ISTMinister of State for Road Transport & Highways, Shipping and Chemicals & Fertilizers, Shri Mansukh L. Mandaviya, in a written reply to the...
FDA approves Imbruvica to treat chronic graft versus host disease Ruby Khatun Khatun7 Aug 2017 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft...
NPPA re-fixes price of Bactrafuz-M cream Ruby Khatun Khatun7 Aug 2017 9:30 AM ISTThrough a recent corrigendum, NPPA had re-fixed the price of Fusidic Acid + Mometasone Furoate (Bactrafuz-M cream).Medical Dialogues had earlier...
hCue joins hand with CAMS to Help Pharmacy Retailers and Distributors Across India Ruby Khatun Khatun7 Aug 2017 9:19 AM ISTChennai: CAMS (Computer Age Management Services), a leading and integral part of Indian financial infrastructure co-owned by NSE Strategic Investment...
FDA panel votes against approval of J&J arthritis drug Ruby Khatun Khatun7 Aug 2017 9:18 AM ISTThe benefits of Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab do not outweigh the risks, an advisory panel to the U.S. Food...
